HemoHim G Gains International Popularity
HemoHim G, developed by Kolmar BNH and distributed by Atomy, has achieved notable success across international markets. This Korean health functional food, designed to enhance immune function and reduce fatigue, has gained recognition worldwide for its quality and effectiveness.
Developed in 2006 by Kolmar BNH, HemoHim is Korea’s first individually-approved health functional food. It is crafted from natural domestic ingredients including angelica gigas, cnidium officinale, and paeonia japonica. This formulation has earned consumer trust over nearly two decades, driven by Kolmar BNH’s commitment to rigorous quality control.
Global Reach and Success
HemoHim, distributed by Atomy, is now available in about 20 countries, including major markets such as the United States and China. Since its launch, it has achieved over KRW 2 trillion in cumulative domestic and international sales, with exports exceeding USD 200 million. This remarkable success reflects HemoHim’s growing reputation and the effectiveness of its quality control measures.
Commitment to Quality
Kolmar BNH’s dedication to quality is evident in its stringent oversight of raw material cultivation. The company has implemented robust measures to ensure the safety of its primary ingredients—Korean angelica gigas Nakai, cnidium officinale, and paeonia japonica. A dedicated food safety team oversees the cultivation processes, providing technology and educational support to farming partners, while conducting thorough inspections to confirm the safety, stability, and efficacy of these ingredients.
Innovative Quality Control Measures
Kolmar BNH has further strengthened its quality control through the development of advanced genetic testing methods. In July, the company patented a genetic analysis method known as SCAR Marker, which identifies the origin of Korean angelica gigas by recognising specific genetic regions. Additionally, Kolmar BNH has employed PCR (polymerase chain reaction) analysis for cnidium officinale and paeonia japonica, securing patent registration for these methods two years ago. These innovations ensure the purity and authenticity of the raw materials, preventing contamination and preserving product quality.
Focus on Safety and Research
Safety remains a top priority for HemoHim G, the international version of HemoHim. In April, Kolmar BNH published a study on HemoHim G in the SCIE-ranked journal ‘Toxicological Research,’ showcasing its safety and adherence to OECD guidelines. This study is pivotal for obtaining safety approvals in various countries and securing intellectual property rights with reliable results.
Tailored for Global Markets
HemoHim G is formulated to meet the food regulations of various countries, with adjustments made to raw materials and ingredient ratios to appeal to a broader audience. The product features a blend of angelica sinensis, ligusticum chuanxiong, and paeonia lactiflora, carefully chosen through rigorous quality control and provenance processes. The enhanced taste and aroma of HemoHim G make it a more attractive option for international consumers.
Kolmar BNH is committed to ongoing research and development to maintain and enhance HemoHim’s global success. The company’s dedication to quality control and innovation ensures that HemoHim will continue to be a leading brand in the international health functional food market.
HemoHim has firmly established itself as a leading K-health functional food brand on the global stage, said a Kolmar BNH official. “We are committed to ongoing research and development to enhance the reliability and effectiveness of our products further.
